Tenders Are Invited For Multicenter, Randomized, Double-Blind Clinical Trial To Evaluate The Efficacy And Safety Of Etanercept Compared To Placebo In The Treatment Of Patients With Sapho Syndrome
Tenders Are Invited For Multicenter, Randomized, Double-Blind Clinical Trial To Evaluate The Efficacy And Safety Of Etanercept Compared To Placebo In The Treatment Of Patients With Sapho Syndrome
Multicenter, Randomized, Double-Blind Clinical Trial To Evaluate The Efficacy And Safety Of Etanercept Compared To Placebo In The Treatment Of Patients With Sapho Syndrome . The Subject Of The Order Is Comprehensive Supervision Over The Implementation Of A Clinical Trial Under The Project: Multi-Center, Randomized, Double-Blind Clinical Trial Assessing The Effectiveness And Safety Of Etanercept Compared To Placebo In The Treatment Of Patients With Sapho Syndrome. The Project Is Financed By The Medical Research Agency (Co-Financing Agreement No. 2022/Abm/01/0000300). A Detailed Description Of The Subject Of The Contract Is Specified In Annex 2 To The Tor.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
